OPTN Evaluation Plan - Organ Procurement and Transplantation ...

Policy 8.5.A: Candidate Classifications 16Policy 8.5.C: Informed Consent for Kidneys Based on KDPI Greater than 85% 16Policy 8.5.E: Allocation of Kidneys by Blood Type 17Policy 8.5.G: Highly Sensitized Candidates 17Policy 9.1.A: Adult Status 1A Requirements 18Policy 9.1.B: Pediatric Status 1A Requirements 18Policy 9.1.C: Pediatric Status 1B 19Policy 9.2: Status and Laboratory Values Update Schedule 19Policy 9.3.D: Specific MELD/PELD Exceptions 20Policy 9.3.G: Candidates with Hepatocellular Carcinoma 20Policy 9.3.H: MELD/PELD Score Exception Extensions 21Policy 10.1.F: The LAS Calculation 21Policy 10.2.B: Lung Candidates with Exceptional Cases 22Policy 11.4.B: Kidney-Pancreas Waiting Time Criteria for Candidates At Least 18 Years Old 22Policy 13.2: Potential KPD Donor Requirements for Participation 23Policy 13.11: Transportation of Kidneys 23Policy 14.2.A: ILDA Requirements for Kidney Recovery Hospitals 24Policy 14.2.B: ILDA Required Protocols for Kidney Recovery Hospitals 25Policy 14.3.A.i: Living Kidney Donor Informed Consent for Evaluation of Potential Living Donors 26Policy 14.3.A.ii: Living Kidney Donor Informed Consent Requirements 28Policy 14.4.A: Living Donor Blood Type Determination 29Policy 14.4.A.i: Living Donor Blood Subtype Determination 30Policy 14.4.B: Living Kidney Donor Medical Evaluation Requirements 31Policy 14.5.A: Living Kidney Donor Psychosocial Evaluation Requirements 35Policy 14.6: Registration and Blood Type Verification of Living Donors before Donation 36Policy 15.1: Patient Safety Contact 37Policy 15.3: Informed Consent of Transmissible Disease Risk 37Policy 15.4.A: Transplant Program Requirements 37Policy 15.4.B: Living Donor Recovery Hospital and Host OPO Requirements 38